Vector-encoded helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2287-2296

  Ramachandran, Mohanraj ^a   Jin, Chuan ^a   Yu, Di ^a   Eriksson, Fredrik ^a   Essand, Magnus ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; B7 ANTIGEN; BACTERIAL PROTEIN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; IL10 PROTEIN, HUMAN; IL10 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; FLOW CYTOMETRY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LYMPHATIC DRAINAGE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; TH1 CELL; UPREGULATION; ADENOVIRIDAE; ANIMAL; CELL MOTION; CYTOLOGY; GENE VECTOR; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, DIFFERENTIATION; BACTERIAL PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; DENDRITIC CELLS; GENETIC VECTORS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; INTERLEUKIN-12; MICE; TH1 CELLS;

EID: 84907031432     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400339     Document Type: Article

References (49)

1. Blaser, M. J. 1993. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol. 1: 255-260.
2. Wisniewski, R. M., and D. A. Peura. 1997. Helicobacter pylori: beyond peptic ulcer disease. Gastroenterologist 5: 295-305.
3. Telford, J. L., A. Covacci, R. Rappuoli, and P. Chiara. 1997. Immunobiology of Helicobacter pylori infection. Curr. Opin. Immunol. 9: 498-503.
4. Montecucco, C., and M. de Bernard. 2003. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 5: 715-721.
5. Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C. Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Montecucco, and F. Rossi. 2000. The neutrophilactivating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191: 1467-1476.
6. Iankov, I. D., M. J. Federspiel, and E. Galanis. 2013. Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens. Vaccine 31: 4795-4801.
7. Codolo, G., M. Fassan, F. Munari, A. Volpe, P. Bassi, M. Rugge, F. Pagano, M. M. D'Elios, and M. de Bernard. 2012. HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol. Immunother. 61: 31-40.
8. Iankov, I. D., C. Allen, M. J. Federspiel, R. M. Myers, K. W. Peng, J. N. Ingle, S. J. Russell, and E. Galanis. 2012. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Mol. Ther. 20: 1139-1147.
9. Ramachandran, M., D. Yu, A. Wanders, M. Essand, and F. Eriksson. 2013. An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophilactivating protein with therapeutic effects on neuroendocrine tumors. Mol. Ther. 21: 2008-2018.
10. Evans, D. J., Jr., D. G. Evans, T. Takemura, H. Nakano, H. C. Lampert, D. Y. Graham, D. N. Granger, and P. R. Kvietys. 1995. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63: 2213-2220.
11. Mooney, C., J. Keenan, D. Munster, I. Wilson, R. Allardyce, P. Bagshaw, B. Chapman, and V. Chadwick. 1991. Neutrophil activation by Helicobacter pylori. Gut 32: 853-857.
12. Amedei, A., A. Cappon, G. Codolo, A. Cabrelle, A. Polenghi, M. Benagiano, E. Tasca, A. Azzurri, M. M. D'Elios, G. Del Prete, and M. de Bernard. 2006. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 116: 1092-1101.
13. D'Elios, M. M., A. Amedei, A. Cappon, G. Del Prete, and M. de Bernard. 2007. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol. Med. Microbiol. 50: 157-164.
14. Nishioka, H., I. Baesso, G. Semenzato, L. Trentin, R. Rappuoli, G. Del Giudice, and C. Montecucco. 2003. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. Eur. J. Immunol. 33: 840-849.
15. Polenghi, A., F. Bossi, F. Fischetti, P. Durigutto, A. Cabrelle, N. Tamassia, M. A. Cassatella, C. Montecucco, F. Tedesco, and M. de Bernard. 2007. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J. Immunol. 178: 1312-1320.
16. Montemurro, P., G. Barbuti, W. G. Dundon, G. Del Giudice, R. Rappuoli, M. Colucci, P. De Rinaldis, C. Montecucco, N. Semeraro, and E. Papini. 2001. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J. Infect. Dis. 183: 1055-1062.
17. Codolo, G., P. Mazzi, A. Amedei, G. Del Prete, G. Berton, M. M. D'Elios, and M. de Bernard. 2008. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell. Microbiol. 10: 2355-2363.
18. Del Prete, G., L. Chiumiento, A. Amedei, M. Piazza, M. M. D'Elios, G. Codolo, M. de Bernard, M. Masetti, and F. Bruschi. 2008. Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophilactivating protein. J. Allergy Clin. Immunol. 122: 908-913.e5.
19. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
20. Torres-Aguilar, H., S. R. Aguilar-Ruiz, G. González-Pérez, R. Munguía, S. Bajaña, M. A. Meraz-Ríos, and C. Sánchez-Torres. 2010. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. 184: 1765-1775.
21. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
22. Moser, M. 2003. Dendritic cells in immunity and tolerance: do they display opposite functions? Immunity 19: 5-8.
23. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
24. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1: 199-205.
25. Kaebisch, R., R. Mejías-Luque, C. Prinz, and M. Gerhard. 2014. Helicobacter pylori cytotoxin-associated gene A impairs human dendritic cell maturation and function through IL-10-mediated activation of STAT3. J. Immunol. 192: 316-323.
26. Kranzer, K., A. Eckhardt, M. Aigner, G. Knoll, L. Deml, C. Speth, N. Lehn, M. Rehli, and W. Schneider-Brachert. 2004. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 72: 4416-4423.
27. Barash, S., W. Wang, and Y. Shi. 2002. Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem. Biophys. Res. Commun. 294: 835-842.
28. Danielsson, A., H. Dzojic, B. Nilsson, and M. Essand. 2008. Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region. Cancer Gene Ther. 15: 203-213.
29. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776.
30. Carlsson, B., W. S. Cheng, T. H. Tötterman, and M. Essand. 2003. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65- modified dendritic cells as stimulators. Br. J. Haematol. 121: 428-438.
31. Byun, E. H., W. S. Kim, J. S. Kim, I. D. Jung, Y. M. Park, H. J. Kim, S. N. Cho, and S. J. Shin. 2012. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response. FASEB J. 26: 2695-2711.
32. Kao, J. Y., M. Zhang, M. J. Miller, J. C. Mills, B. Wang, M. Liu, K. A. Eaton, W. Zou, B. E. Berndt, T. S. Cole, et al. 2010. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138: 1046-1054.
33. Salama, N. R., M. L. Hartung, and A. Müller. 2013. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11: 385-399.
34. Ma, D. Y., and E. A. Clark. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 21: 265-272.
35. Chang, L. L., S. W. Wang, I. C. Wu, F. J. Yu, Y. C. Su, Y. P. Chen, D. C. Wu, C. H. Kuo, and C. H. Hung. 2012. Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients. Appl. Microbiol. Biotechnol. 96: 211-220.
36. Knipp, U., S. Birkholz, W. Kaup, K. Mahnke, and W. Opferkuch. 1994. Suppression of human mononuclear cell response by Helicobacter pylori: effects on isolated monocytes and lymphocytes. FEMS Immunol. Med. Microbiol. 8: 157-166.
37. Spö rri, R., and C. Reis e Sousa. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6: 163-170.
38. Kerkar, S. P., R. S. Goldszmid, P. Muranski, D. Chinnasamy, Z. Yu, R. N. Reger, A. J. Leonardi, R. A. Morgan, E. Wang, F. M. Marincola, et al. 2011. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J. Clin. Invest. 121: 4746-4757.
39. Zhang, L., S. P. Kerkar, Z. Yu, Z. Zheng, S. Yang, N. P. Restifo, S. A. Rosenberg, and R. A. Morgan. 2011. Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment. Mol. Ther. 19: 751-759.
40. Chinnasamy, D., Z. Yu, S. P. Kerkar, L. Zhang, R. A. Morgan, N. P. Restifo, and S. A. Rosenberg. 2012. Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clin. Cancer Res. 18: 1672-1683.
41. Kerkar, S. P., A. J. Leonardi, N. van Panhuys, L. Zhang, Z. Yu, J. G. Crompton, J. H. Pan, D. C. Palmer, R. A. Morgan, S. A. Rosenberg, and N. P. Restifo. 2013. Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol. Ther. 21: 1369-1377.
42. Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85: 9-18; quiz 18, 21.
43. Pellegrini, P., A. M. Berghella, T. Del Beato, S. Cicia, D. Adorno, and C. U. Casciani. 1996. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol. Immunother. 42: 1-8.
44. Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246.
45. Chen, W., D. Shu, and V. S. Chadwick. 2001. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J. Gastroenterol. Hepatol. 16: 377-383.
46. Cravens, P. D., and P. E. Lipsky. 2002. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol. Cell Biol. 80: 497-505.
47. Martin-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
48. Liu, T., T. Matsuguchi, N. Tsuboi, T. Yajima, and Y. Yoshikai. 2002. Differences in expression of Toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 70: 6638-6645.
49. Maroof, A., L. Beattie, A. Kirby, M. Coles, and P. M. Kaye. 2009. Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen. J. Immunol. 183: 7095-7103.